Literature DB >> 23325088

Mild hyponatremia is associated with an increased risk of death in an ambulatory setting.

Fabrice Gankam-Kengne1, Colby Ayers, Amit Khera, James de Lemos, Naim M Maalouf.   

Abstract

Hyponatremia is a common disorder associated with higher mortality in hospitalized patients, but its impact in an ambulatory setting remains unclear. Here we used data from the Dallas Heart Study, a prospective multiethnic cohort study that included ambulatory individuals, to determine the prevalence and determinants of hyponatremia (serum sodium <135 mEq/l), and its impact on mortality. The analysis included 3551 individuals with a median age of 43 years followed up over a median of 8.4 years. The sample weight-adjusted prevalence of hyponatremia was 6.9%. Hyponatremia was mild (median serum sodium: 133 mEq/l), and was significantly associated with age, black ethnicity, presence of cirrhosis or congestive heart failure, and use of selective serotonin reuptake inhibitors. By the end of the follow-up period, there were 202 deaths including 29 in hyponatremic individuals. The unadjusted hazard ratio for hyponatremia and death was 1.94. Hyponatremia remained significantly associated with mortality after adjustment for age, gender, ethnicity, diabetes, hypertension, dyslipidemia, smoking, alcohol use, renal function, plasma C-reactive protein, use of antiepileptic drugs and selective serotonin reuptake inhibitors, and history of congestive heart failure, cirrhosis, and cancer (hazard ratio of 1.75). Thus, mild hyponatremia is associated with an increased risk of death in a young and ethnically diverse community population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23325088     DOI: 10.1038/ki.2012.459

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  28 in total

1.  Hyponatremia and mortality among very elderly residents in a geriatric health service facility.

Authors:  Tamayo Naka; Kentaro Kohagura; Masako Kochi; Yusuke Ohya
Journal:  Clin Exp Nephrol       Date:  2018-06-27       Impact factor: 2.801

2.  Reply to SN Thornton.

Authors:  Janet C King; Kristin J Reimers; Michael H Alderman; David A McCarron
Journal:  Adv Nutr       Date:  2015-05-15       Impact factor: 8.701

3.  Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM).

Authors:  E Sbardella; A M Isidori; G Arnaldi; M Arosio; C Barone; A Benso; R Berardi; G Capasso; M Caprio; F Ceccato; G Corona; S Della Casa; L De Nicola; M Faustini-Fustini; E Fiaccadori; L Gesualdo; S Gori; A Lania; G Mantovani; P Menè; G Parenti; C Pinto; R Pivonello; P Razzore; G Regolisti; C Scaroni; F Trepiccione; A Lenzi; A Peri
Journal:  J Endocrinol Invest       Date:  2017-11-20       Impact factor: 4.256

4.  Serum Sodium and Cognition in Older Community-Dwelling Men.

Authors:  Kristen L Nowak; Kristine Yaffe; Eric S Orwoll; Joachim H Ix; Zhiying You; Elizabeth Barrett-Connor; Andrew R Hoffman; Michel Chonchol
Journal:  Clin J Am Soc Nephrol       Date:  2018-02-08       Impact factor: 8.237

Review 5.  Mild Chronic Hyponatremia in the Ambulatory Setting: Significance and Management.

Authors:  Helbert Rondon-Berrios; Tomas Berl
Journal:  Clin J Am Soc Nephrol       Date:  2015-06-24       Impact factor: 8.237

6.  Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome.

Authors:  Vildan Tasdemir; Ali Kemal Oguz; Irmak Sayın; Ihsan Ergun
Journal:  Int Urol Nephrol       Date:  2015-10-22       Impact factor: 2.370

7.  Management of hyponatremia in various clinical situations.

Authors:  Michael L Moritz; Juan C Ayus
Journal:  Curr Treat Options Neurol       Date:  2014-09       Impact factor: 3.598

Review 8.  Dysnatremias in patients with kidney disease.

Authors:  Sara Combs; Tomas Berl
Journal:  Am J Kidney Dis       Date:  2013-11-14       Impact factor: 8.860

9.  The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium.

Authors:  Fabio A B Schutz; Wanling Xie; Frede Donskov; Monica Sircar; David F McDermott; Brian I Rini; Neeraj Agarwal; Sumanta Kumar Pal; Sandy Srinivas; Christian Kollmannsberger; Scott A North; Lori A Wood; Ulka Vaishampayan; Min-Han Tan; Mary J Mackenzie; Jae Lyun Lee; Sun-Young Rha; Takeshi Yuasa; Daniel Y C Heng; Toni K Choueiri
Journal:  Eur Urol       Date:  2013-10-26       Impact factor: 20.096

10.  Assocıatıons between mıld hyponatremıa and gerıatrıc syndromes ın outpatıent settıngs.

Authors:  Cihan Heybeli; Lee Smith; Pinar Soysal
Journal:  Int Urol Nephrol       Date:  2021-02-18       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.